Article

Peripherin: a novel early diagnostic and prognostic plasmatic biomarker in Amyotrophic Lateral Sclerosis

2025-01-27

Abstract excerpt

<h4>Background and aim</h4> Motor neuron diseases (MND) are heterogeneous and complex neurodegenerative disorders. Biomarkers could facilitate early diagnosis, prognosis determination, and patient stratification. Among the most studied biomarkers are neurofilaments, with peripherin (PRPH), a specific type predominantly expressed in peripheral nervous system neurons, gaining attention. To date, no studies have eval...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1bb84635-ac50-5ccf-9a0b-03359b97e950
DOI: 10.1101/2025.01.24.25321038

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Peripherin: a novel early diagnostic and prognostic plasmatic biomarker in Amyotrophic Lateral SclerosisDOI 10.1101/2025.01.24.25321038Read

Peripherin, a new promising biomarker in neurological disordersSemantic proximity Read

Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applicationsSemantic proximity Read

Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics.Semantic proximity Read

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.Semantic proximity Read

Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease.Semantic proximity Read

A Frameshift Deletion in Peripherin Gene Associated with Amyotrophic Lateral SclerosisSemantic proximity Read

Population-based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral SclerosisSemantic proximity Read

Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter study.Semantic proximity Read

Prognostic Clinical and Biological Markers for Amyotrophic Lateral Sclerosis Disease Progression: Validation and Implications for Clinical Trial Design and AnalysisSemantic proximity Read

Skeletal muscle biomarkers of amyotrophic lateral sclerosis: a large-scale, multi-cohort proteomic studySemantic proximity Read

The Role of CHI3L1 Plasmatic Levels in Amyotrophic Lateral SclerosisSemantic proximity Read

Biomarkers in Motor Neuron Disease: A State of the Art ReviewSemantic proximity Read